TWI702289B - 用於胜肽生產之融合夥伴 - Google Patents

用於胜肽生產之融合夥伴 Download PDF

Info

Publication number
TWI702289B
TWI702289B TW104140109A TW104140109A TWI702289B TW I702289 B TWI702289 B TW I702289B TW 104140109 A TW104140109 A TW 104140109A TW 104140109 A TW104140109 A TW 104140109A TW I702289 B TWI702289 B TW I702289B
Authority
TW
Taiwan
Prior art keywords
seq
protein
fusion protein
pseudomonas
recombinant fusion
Prior art date
Application number
TW104140109A
Other languages
English (en)
Chinese (zh)
Other versions
TW201629226A (zh
Inventor
戴安Ｍ 里托雷克
亞當 強普曼
托本Ｒ 布魯克
鴻范 金
Original Assignee
美商費奈克斯股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商費奈克斯股份有限公司 filed Critical 美商費奈克斯股份有限公司
Publication of TW201629226A publication Critical patent/TW201629226A/zh
Application granted granted Critical
Publication of TWI702289B publication Critical patent/TWI702289B/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21009—Enteropeptidase (3.4.21.9), i.e. enterokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
TW104140109A 2014-12-01 2015-12-01 用於胜肽生產之融合夥伴 TWI702289B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462086119P 2014-12-01 2014-12-01
US62/086,119 2014-12-01

Publications (2)

Publication Number Publication Date
TW201629226A TW201629226A (zh) 2016-08-16
TWI702289B true TWI702289B (zh) 2020-08-21

Family

ID=56092296

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104140109A TWI702289B (zh) 2014-12-01 2015-12-01 用於胜肽生產之融合夥伴

Country Status (16)

Country Link
US (2) US10118956B2 (enExample)
EP (1) EP3227455B1 (enExample)
JP (2) JP6817939B2 (enExample)
KR (1) KR102353262B1 (enExample)
CN (2) CN113444183B (enExample)
AR (1) AR102865A1 (enExample)
AU (1) AU2015355242B2 (enExample)
CA (1) CA2966358C (enExample)
DK (1) DK3227455T3 (enExample)
ES (1) ES2952405T3 (enExample)
MX (1) MX386884B (enExample)
NZ (1) NZ732400A (enExample)
RU (1) RU2017123283A (enExample)
SG (1) SG11201704362VA (enExample)
TW (1) TWI702289B (enExample)
WO (1) WO2016089782A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113444183B (zh) 2014-12-01 2025-06-17 佩利肯科技控股公司 用于肽生产的融合伴侣
US20160357801A1 (en) 2015-05-15 2016-12-08 Foogal Incorporated Consumption notification from personal food inventory
EP3700921A4 (en) 2017-10-27 2021-12-15 Pfenex Inc. Method for production of recombinant erwinia asparaginase
JP7358347B2 (ja) 2017-10-27 2023-10-10 フェネックス インク． 組み換えＥ．ｃｏｌｉアスパラギナーゼの製造のための方法
US11267863B2 (en) 2018-01-19 2022-03-08 Pepgene Inc. N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same
CN108191981B (zh) * 2018-02-06 2020-11-03 美药星（南京）制药有限公司 一种利拉鲁肽中间体多肽的制备方法
KR102017542B1 (ko) * 2018-02-14 2019-09-03 주식회사 펩진 융합 폴리펩타이드를 이용하여 글루카곤 유사 펩타이드-2 또는 이의 유사체를 생산하는 방법
KR102017540B1 (ko) * 2018-02-14 2019-09-03 주식회사 펩진 융합 폴리펩타이드를 이용하여 글루카곤 유사 펩타이드-1 또는 이의 유사체를 생산하는 방법
KR102009709B1 (ko) * 2018-02-14 2019-08-12 주식회사 펩진 융합 폴리펩타이드를 이용하여 인간 부갑상선 호르몬 1-84를 생산하는 방법
CN108977423A (zh) * 2018-08-17 2018-12-11 集美大学 一种从猪肺中分离提纯血管紧张素转化酶的方法
KR102011291B1 (ko) * 2018-12-05 2019-10-21 주식회사 펩진 신규한 융합 폴리펩타이드 및 이를 이용하여 인간 부갑상선 호르몬 1-34를 생산하는 방법
EP3893870A1 (en) 2018-12-13 2021-10-20 Huya Bioscience International LLC Sulcardine administration for treatment of acute atrial fibrillation
CN110305223B (zh) * 2019-06-26 2022-05-13 重庆派金生物科技有限公司 重组串联融合蛋白制备目标多肽的方法
KR20210010367A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 인간부갑상선호르몬1-34 생산용 융합태그
KR20210010366A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 글루카곤 유사 펩타이드-1 또는 이의 유사체 생산용 융합태그
KR20210010368A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 글루카곤 유사 펩타이드-2 또는 이의 유사체 생산용 융합태그
EP4056584A4 (en) * 2019-11-08 2024-06-05 Korea Institute of Ocean Science & Technology NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
WO2022016118A2 (en) * 2020-07-17 2022-01-20 Cb Therapeutics, Inc. Prenyltransferase enzymes
CN113151296B (zh) * 2021-03-22 2022-09-13 云南中烟工业有限责任公司 一种烟草热激蛋白相关的基因及其应用
CN112941058B (zh) * 2021-04-02 2023-12-05 重庆科润生物医药研发有限公司 一种重组溶组织梭菌ii型胶原酶及其制备方法和应用
CN113025599B (zh) * 2021-04-02 2023-09-12 重庆科润生物医药研发有限公司 一种重组溶组织梭菌i型胶原酶及其制备方法和应用
US20230100757A1 (en) * 2021-06-10 2023-03-30 Pfenex Inc. Bacterial hosts for recombinant protein expression
EP4380955A1 (en) * 2021-08-06 2024-06-12 Roche Diagnostics GmbH Chimeric igg-fc-binding ligand polypeptide and uses thereof for igg affinity purification
US20240383959A1 (en) * 2021-09-09 2024-11-21 Northwestern University Cell-free methods and compositions comprising tagless therapeutic hormones
CN114350587B (zh) * 2022-01-24 2023-10-31 修实生物医药(南通)有限公司 一种基因重组串联表达利那洛肽的工程菌
CN115109766A (zh) * 2022-02-14 2022-09-27 上海理工大学 一种耐高温金属蛋白酶及其编码基因和应用
WO2024035782A1 (en) * 2022-08-10 2024-02-15 Aav Gene Therapeutics, Inc. Aav-mediated intramuscular delivery of insulin
WO2025081111A1 (en) * 2023-10-12 2025-04-17 The University Of Chicago Methods and compositions for characterizing rna-binding protein binding sites by in-situ reverse transcription-based sequencing

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
US5013653A (en) 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
US7150974B1 (en) 1991-04-05 2006-12-19 The General Hospital Corporation Parathyroid hormone receptor binding method
EP0604580A1 (en) 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES
CA2125467C (en) 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
US5935824A (en) 1996-01-31 1999-08-10 Technologene, Inc. Protein expression system
CA2198966C (en) 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme
JPH1175879A (ja) * 1997-07-08 1999-03-23 Toyota Central Res & Dev Lab Inc プロテインジスルフィドイソメラーゼを含有する融合タンパク質をコードするｄｎａ
US5989868A (en) 1997-09-12 1999-11-23 The Board Of Regents Of The University Of Oklahoma Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli
KR100627590B1 (ko) 1998-01-30 2006-09-25 다이이치 아스비오파마 가부시키가이샤 보조 펩타이드를 사용하는 펩타이드의 제조방법
US6242219B1 (en) 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production
WO2001098366A2 (en) 2000-06-19 2001-12-27 Dyax Corp. Enterokinase cleavage sequences and their use
JP2002262873A (ja) 2001-03-06 2002-09-17 Inst Of Physical & Chemical Res タンパク質ドメインの製造方法及びその方法により得られたドメインを用いるタンパク質の立体構造解析方法
JP4262594B2 (ja) 2001-06-22 2009-05-13 エフ．ホフマン−ラ ロシュ アーゲー レトロウイルス表面糖タンパク質を含む可溶性複合体
JP4088584B2 (ja) 2001-07-26 2008-05-21 アドバンスド プロテイン テクノロジーズ コーポレイション 融合タンパク質から目的タンパク質を分離する方法。
ATE419265T1 (de) 2002-07-03 2009-01-15 Dow Global Technologies Inc Benzoat- und antranilatinduzierbare promotoren
CA2495145A1 (en) 2002-08-09 2004-02-19 National Research Council Of Canada Staphylococcal nuclease fusion proteins for the production of recombinant peptides
US7208585B2 (en) 2002-09-18 2007-04-24 Genencor International, Inc. Protein purification
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US20070026501A1 (en) 2003-04-18 2007-02-01 Joe Chiba Immunogen, composition for immulogical use and process for producing antibody using the same
JP2005110591A (ja) 2003-10-08 2005-04-28 Sekisui Chem Co Ltd 蛋白質の分離方法
WO2005052151A1 (en) 2003-11-19 2005-06-09 Dow Global Technologies Inc. Improved protein expression systems
EP2327718B1 (en) 2003-11-21 2016-03-23 Pfenex, Inc. Improved expression systems with SEC-system secretion
EP1689877A1 (en) 2003-11-24 2006-08-16 Novo Nordisk A/S Fusion proteins and methods of cleavage of such proteins
KR20120076377A (ko) 2004-01-16 2012-07-09 다우 글로벌 테크놀로지스 엘엘씨 슈도모나스 플루오레센스에서의 포유류 단백질의 발현
WO2006078273A2 (en) 2004-04-26 2006-07-27 The United States Of America As Represented By Teh Secretary Of Health And Human Services, Nih Methods and compositions for producing recombinant proteins
EP1748071A4 (en) 2004-05-21 2009-01-07 Takara Bio Inc PROCESS FOR PRODUCTION OF POLYPEPTIDE
EP2412816B1 (en) * 2004-07-26 2014-12-03 Pfenex Inc. Process for improved protein expression by strain engineering
WO2006016370A2 (en) 2004-08-11 2006-02-16 Ramot At Tel Aviv University Ltd. Soluble fusion proteins comprising heterologous polypeptides
US7585943B2 (en) 2005-04-20 2009-09-08 Viromed Co., Ltd. Compositions and methods for fusion protein separation
CN101193906B (zh) 2005-06-06 2012-09-05 陶氏环球技术公司 细菌宿主细胞中甘露糖醇诱导的启动子系统
BRPI0711878A2 (pt) 2006-05-30 2012-01-10 Dow Global Technologies Inc método de otimização do códon
EP2363495B1 (en) 2006-05-30 2019-07-24 Pfenex Inc. Anthrax vaccine
EP1873251A1 (en) 2006-06-29 2008-01-02 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Expression vector(s) for enhanced expression of a protein of interest in eukaryotic or prokaryotic host cells
CA2677179C (en) 2007-01-31 2016-02-16 Dow Global Technologies Inc. Bacterial leader sequences for increased expression
CA2685326A1 (en) 2007-04-27 2008-11-06 Dow Global Technologies Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2009019715A1 (en) 2007-08-09 2009-02-12 Usv Limited Novel orthogonal process for purification of recombinant human parathyroid hormone (rhpth) (1-34)
EP2594646A3 (en) * 2007-09-21 2013-11-06 BASF Plant Science GmbH Plant with increased yield
WO2009086132A2 (en) 2007-12-20 2009-07-09 University Of Southern California Design of spacers to increase the expression of recombinant fusion proteins
EP2127678A1 (en) 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology
JP2010006745A (ja) * 2008-06-27 2010-01-14 Sekisui Chem Co Ltd 融合タンパク質、融合タンパク質固定化担体、化合物のスクリーニング方法、スクリーニング用組成物、並びに、スクリーニング用キット
CN102239183B (zh) 2008-12-04 2017-06-30 韩国生命工学研究院 大量分泌的蛋白的筛选和它们作为融合配偶体在重组蛋白制备中应用
US8455218B2 (en) 2010-04-01 2013-06-04 Pfenex, Inc. Methods for G-CSF production in a Pseudomonas host cell
WO2011151714A1 (en) 2010-06-04 2011-12-08 Lupin Limited Modified sak gene for the production of recombinant proteins
AR086250A1 (es) 2011-05-05 2013-11-27 Hoffmann La Roche Polipeptido de fusion presentador de una secuencia de aminoacidos y utilizacion del mismo
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
CN113444183B (zh) 2014-12-01 2025-06-17 佩利肯科技控股公司 用于肽生产的融合伴侣
CA2974343A1 (en) 2015-02-13 2016-08-18 Sekisui Chemical Co., Ltd. Nucleic acid, fusion protein, recombined cell, and isoprene or cyclic terpene production method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Charles H. Squires et al., "Heterologous Protein Production in P. fluorescens", BioProcess International, Dec 2004, page 54-58. *
Christos A. Kyratsous et al, "Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli", Gene, 2009 Jul 1;440(1-2):9-15. Epub 2009 Mar 26. *
Haleh Hamedifar et al., "A Novel Approach for High Level Expression of Soluble Recombinant Human Parathyroid Hormone (rhPTH 1-34) in Escherichia coli", Avicenna J Med Biotechnol, 2013 Jul;5(3):193-201. *
Jin-Ho Ahn et al., "Expression Screening of Fusion Partners from an E. coli Genome for Soluble Expression of Recombinant Proteins in a Cell-Free Protein Synthesis System", PLoS One, 2011;6(11):e26875. Epub 2011 Nov 2. *

Also Published As

Publication number Publication date
US20160159877A1 (en) 2016-06-09
KR102353262B1 (ko) 2022-01-18
TW201629226A (zh) 2016-08-16
ES2952405T3 (es) 2023-10-31
CA2966358A1 (en) 2016-06-09
JP7148579B2 (ja) 2022-10-05
WO2016089782A1 (en) 2016-06-09
EP3227455A4 (en) 2018-07-04
US10118956B2 (en) 2018-11-06
CN113444183A (zh) 2021-09-28
MX386884B (es) 2025-03-19
US10981968B2 (en) 2021-04-20
CN107532190A (zh) 2018-01-02
US20190135889A1 (en) 2019-05-09
CA2966358C (en) 2021-12-07
RU2017123283A (ru) 2019-01-09
CN107532190B (zh) 2021-07-09
BR112017011662A2 (pt) 2018-02-27
JP2017536835A (ja) 2017-12-14
KR20170085129A (ko) 2017-07-21
NZ732400A (en) 2021-07-30
CN113444183B (zh) 2025-06-17
EP3227455A1 (en) 2017-10-11
AR102865A1 (es) 2017-03-29
EP3227455B1 (en) 2023-07-12
SG11201704362VA (en) 2017-06-29
HK1245336A1 (en) 2018-08-24
JP6817939B2 (ja) 2021-01-20
JP2021003117A (ja) 2021-01-14
DK3227455T3 (da) 2023-08-21
AU2015355242B2 (en) 2020-10-08
MX2017006866A (es) 2017-11-15
AU2015355242A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
TWI702289B (zh) 用於胜肽生產之融合夥伴
CN103952425B (zh) 大量分泌的蛋白的筛选和它们作为融合配偶体在重组蛋白制备中应用
AU2016256579B2 (en) Uncoupling growth and protein production
EP1713930B1 (en) Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom
Ben-Bassat Methods for removing N-terminal methionine from recombinant proteins
Wong et al. Escherichia coli: A versatile platform for recombinant protein expression
KR100618563B1 (ko) 셀룰로오스 결합 도메인을 이용한 효모에서 재조합단백질의 제조방법
HK1245336B (en) Fusion partners for peptide production
BR112017011662B1 (pt) Parceiros de fusão para a produção de peptídeo
HK40009188A (en) Signal polypeptide for improved secretion of protein